206 related articles for article (PubMed ID: 32117784)
1. Post-mastectomy Radiotherapy in T1-2 Breast Cancer Patients With One to Three Lymph Node Metastases: A Propensity Score Matching Analysis.
Chen M; Huang Y; Leng Z; Yang G; Li F; Yang H; Hou L
Front Oncol; 2019; 9():1551. PubMed ID: 32117784
[No Abstract] [Full Text] [Related]
2. Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
Xia LY; Xu WY; Zhao Y
PLoS One; 2022; 17(6):e0270528. PubMed ID: 35749525
[TBL] [Abstract][Full Text] [Related]
3. T1-2N1M0 triple-negative breast cancer patients from the SEER database showed potential benefit from post-mastectomy radiotherapy.
Wang X; Xu Y; Guo S; Zhang J; Abe M; Tan H; Wang S; Chen P; Zong L
Oncol Lett; 2020 Jan; 19(1):735-744. PubMed ID: 31897189
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Post-mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: An Analysis of SEER Database.
Wang J; Zhang WW; Lian CL; Sun JY; He ZY; Wu SG
Front Oncol; 2019; 9():747. PubMed ID: 31475106
[No Abstract] [Full Text] [Related]
5. Evaluation of the benefit of post-mastectomy radiotherapy in patients with early-stage breast cancer: A propensity score matching study.
Shi W; Luo Y; Zhao D; Huang H; Pang W
Oncol Lett; 2019 Jun; 17(6):4851-4858. PubMed ID: 31186692
[TBL] [Abstract][Full Text] [Related]
6. The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer.
Zhang L; Tang R; Deng JP; Zhang WW; Lin HX; Wu SG; He ZY
BMC Cancer; 2020 Nov; 20(1):1146. PubMed ID: 33238939
[TBL] [Abstract][Full Text] [Related]
7. Postmastectomy radiation therapy can improve survival for breast cancer patients with 1-3 positive axillary lymph nodes: a retrospective cohort study using the SEER database.
Yang J; Zhang X; Ye Y; Lin Y; Yang Q; Cai H
Transl Cancer Res; 2021 May; 10(5):1984-2001. PubMed ID: 35116521
[TBL] [Abstract][Full Text] [Related]
8. Is There a Role for Post-Mastectomy Radiotherapy for T1-2N1 Breast Cancers With Node-Positive Pathology After Patients Become Node-Negative Pathology Following Neoadjuvant Chemotherapy?
Wang Q; Zhao J; Han X; Er P; Meng X; Shi J; Sun H; Zhu J; Zhu L; Wu S; Zhang W; Sun B
Front Oncol; 2020; 10():892. PubMed ID: 32695661
[No Abstract] [Full Text] [Related]
9. 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.
Zhang WW; Tong Q; Sun JY; Hua X; Long ZQ; Deng JP; Dong Y; Li FY; He ZY; Wu SG; Lin HX
Front Oncol; 2019; 9():270. PubMed ID: 31041190
[No Abstract] [Full Text] [Related]
10. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
Front Oncol; 2022; 12():789198. PubMed ID: 35280719
[TBL] [Abstract][Full Text] [Related]
11. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
12. The Effect of Post-Mastectomy Radiotherapy in Patients With Metaplastic Breast Cancer: A Propensity Score-Matched Analysis of the SEER Database.
Hu J; Tan J; Dong F; Zhang X; Ming J; Huang T
Front Oncol; 2021; 11():593121. PubMed ID: 35096554
[TBL] [Abstract][Full Text] [Related]
13. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
14. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
[TBL] [Abstract][Full Text] [Related]
15. The trade-off of post-mastectomy radiotherapy usage for the breast cancer patients aged 70 years or older: a study based on SEER database.
Lin J; Luo S; Zhang J; Song C
BMC Geriatr; 2023 Oct; 23(1):625. PubMed ID: 37803254
[TBL] [Abstract][Full Text] [Related]
16. Effect of postmastectomy radiotherapy on triple-negative breast cancer with T1-2 and 1-3 positive axillary lymph nodes: a population-based study using the SEER 18 database.
Zhang J; Wang XX; Lian JY; Song CG
Oncotarget; 2019 Aug; 10(50):5245-5252. PubMed ID: 31497253
[TBL] [Abstract][Full Text] [Related]
17. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer.
Smith BD; Smith GL; Haffty BG
J Clin Oncol; 2005 Mar; 23(7):1409-19. PubMed ID: 15735117
[TBL] [Abstract][Full Text] [Related]
18. Real-world impact of postmastectomy radiotherapy in T1-2 breast cancer with one to three positive lymph nodes.
Li FY; Lian CL; Lei J; Wang J; Hua L; He ZY; Wu SG
Ann Transl Med; 2020 Apr; 8(7):489. PubMed ID: 32395533
[TBL] [Abstract][Full Text] [Related]
19. [Effect of postmastectomy radiotherapy on survival outcomes of patients with metaplastic breast cancer].
Cai W; Zhuang Y; Chen J; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1733-1740. PubMed ID: 34916202
[TBL] [Abstract][Full Text] [Related]
20. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer.
Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB
Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
